Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MODV Stock Forecast 2025-2026
$0.90
Current Price
$13.15M
Market Cap
Buy 1
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to MODV Price Targets
+1,233.3%
To High Target of $12.00
+33.3%
To Median Target of $1.20
+27.8%
To Low Target of $1.15
MODV Price Momentum
-2.2%
1 Week Change
-41.6%
1 Month Change
-96.7%
1 Year Change
-92.4%
Year-to-Date Change
-97.3%
From 52W High of $32.82
+3.4%
From 52W Low of $0.87
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching ModivCare (MODV) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on MODV and similar high-potential opportunities.
Latest MODV Stock Price Targets & Analyst Predictions
Based on our analysis of 7 Wall Street analysts, MODV has a neutral consensus with a median price target of $1.20 (ranging from $1.15 to $12.00). The overall analyst rating is Buy (6.5/10). Currently trading at $0.90, the median forecast implies a 33.3% upside. This outlook is supported by 1 Buy, 3 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MODV Analyst Ratings
1
Buy
3
Hold
0
Sell
MODV Price Target Range
Low
$1.15
Average
$1.20
High
$12.00
Current: $0.90
Latest MODV Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MODV.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 12, 2025 | Barrington Research | Michael Petusky | Market Perform | Downgrade | $0.00 |
| Mar 10, 2025 | Stephens & Co. | Raj Kumar | Equal-Weight | Maintains | $3.50 |
| Mar 7, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $6.00 |
| Jan 14, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $10.00 |
| Jan 13, 2025 | Lake Street | Brooks O'Neil | Buy | Maintains | $10.00 |
| Jan 10, 2025 | Stephens & Co. | Raj Kumar | Equal-Weight | Downgrade | $17.00 |
| Nov 18, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $25.00 |
| Nov 8, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $25.00 |
| Oct 3, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $22.00 |
| Sep 17, 2024 | Lake Street | Brooks O'Neil | Buy | Maintains | $30.00 |
| Sep 17, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $19.00 |
| Sep 13, 2024 | Jefferies | Brian Tanquilut | Hold | Maintains | $14.00 |
| Aug 9, 2024 | Barrington Research | Michael Petusky | Outperform | Upgrade | $35.00 |
| May 6, 2024 | Lake Street | Brooks O'Neil | Buy | Upgrade | $50.00 |
| Feb 26, 2024 | Barrington Research | Michael Petusky | Market Perform | Downgrade | $0.00 |
| Feb 23, 2024 | Jefferies | Brian Tanquilut | Hold | Downgrade | $39.00 |
| Feb 23, 2024 | Deutsche Bank | Pito Chickering | Hold | Downgrade | $40.00 |
| Nov 6, 2023 | Barrington Research | Michael Petusky | Outperform | Maintains | $68.00 |
| Aug 7, 2023 | Deutsche Bank | Pito Chickering | Buy | Maintains | $50.00 |
| Aug 7, 2023 | Barrington Research | Michael Petusky | Outperform | Reiterates | $58.00 |
ModivCare Inc. (MODV) Competitors
The following stocks are similar to ModivCare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ModivCare Inc. (MODV) Financial Data
ModivCare Inc. has a market capitalization of $13.15M with a P/E ratio of -0.1x. The company generates $2.75B in trailing twelve-month revenue with a -8.3% profit margin.
Revenue growth is -4.9% quarter-over-quarter, while maintaining an operating margin of -0.7% and return on equity of -951.5%.
Valuation Metrics
Market Cap
$13.15M
Enterprise Value
$1.30B
P/E Ratio
-0.1x
PEG Ratio
0.3x
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
-4.9%
Gross Margin
+15.0%
Operating Margin
-0.7%
Net Margin
-8.3%
EPS Growth
-4.9%
Financial Health
Cash/Price Ratio
+897.7%
Current Ratio
0.8x
Debt/Equity
-16.0x
ROE
-951.5%
ROA
+0.4%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
ModivCare Inc. (MODV) Business Model
About ModivCare Inc.
What They Do
Provides non-emergency medical transportation services.
Business Model
ModivCare generates revenue by offering non-emergency medical transportation (NEMT) services to Medicaid and Medicare Advantage beneficiaries, ensuring patients can access necessary medical appointments. The company also diversifies its income through personal care services and remote patient monitoring, enhancing its role in the healthcare logistics sector.
Additional Information
Founded in 1996, ModivCare plays a significant role in healthcare by addressing the logistical challenges faced by patients lacking transportation. Its services are critical for public health programs and private health plans aimed at improving patient outcomes and controlling healthcare costs.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
23,675
CEO
Mr. L. Heath Sampson CPA
Country
United States
IPO Year
2003
Website
www.modivcare.comModivCare Inc. (MODV) Latest News & Analysis
Latest News
Quick Summary
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for ModivCare, Inc. (NASDAQ:MODV) investors who bought shares before November 3, 2022. More info available at bgandg.com/MODV.
Why It Matters
ModivCare is under investigation for potential claims, which may indicate legal or financial issues, potentially affecting the stock's value and investor confidence.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for investors who purchased ModivCare, Inc. (NASDAQ:MODV) securities before November 3, 2022.
Why It Matters
The investigation into ModivCare may signal potential legal or financial issues, impacting stock performance and investor sentiment. Affected investors could face losses or need to reassess holdings.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Modivcare Inc. (Nasdaq: MODV) acknowledges Joyful Medical Transportation, LLC for its exceptional service in supporting health outcomes, highlighting its commitment to care in October 2024.
Why It Matters
Modivcare's recognition of Joyful Medical Transportation highlights its commitment to quality service, potentially enhancing its reputation and customer loyalty, which can positively impact stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for investors who purchased ModivCare (NASDAQ:MODV) securities before November 3, 2022. Further details are available on their website.
Why It Matters
The investigation into ModivCare may signal potential legal issues or financial discrepancies, impacting stock performance and investor confidence.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Bragar Eagel & Squire is investigating potential claims against ModivCare, Inc. related to a class action filed on January 29, 2025, regarding possible fiduciary duty breaches by its board.
Why It Matters
Legal investigations and class action complaints can lead to significant financial liabilities for ModivCare, potentially impacting stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for investors of ModivCare, Inc. (NASDAQ:MODV) who purchased securities before November 3, 2022.
Why It Matters
The investigation into ModivCare could indicate potential legal issues or financial irregularities, impacting stock performance and investor sentiment.
Source: Accesswire
Market Sentiment:
Neutral
Frequently Asked Questions About MODV Stock
What is ModivCare Inc.'s (MODV) stock forecast for 2025?
Based on our analysis of 7 Wall Street analysts, ModivCare Inc. (MODV) has a median price target of $1.20. The highest price target is $12.00 and the lowest is $1.15.
Is MODV stock a good investment in 2025?
According to current analyst ratings, MODV has 1 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.90. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MODV stock?
Wall Street analysts predict MODV stock could reach $1.20 in the next 12 months. This represents a 33.3% increase from the current price of $0.90. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is ModivCare Inc.'s business model?
ModivCare generates revenue by offering non-emergency medical transportation (NEMT) services to Medicaid and Medicare Advantage beneficiaries, ensuring patients can access necessary medical appointments. The company also diversifies its income through personal care services and remote patient monitoring, enhancing its role in the healthcare logistics sector.
What is the highest forecasted price for MODV ModivCare Inc.?
The highest price target for MODV is $12.00 from at , which represents a 1,233.3% increase from the current price of $0.90.
What is the lowest forecasted price for MODV ModivCare Inc.?
The lowest price target for MODV is $1.15 from at , which represents a 27.8% increase from the current price of $0.90.
What is the overall MODV consensus from analysts for ModivCare Inc.?
The overall analyst consensus for MODV is neutral. Out of 7 Wall Street analysts, 1 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $1.20.
How accurate are MODV stock price projections?
Stock price projections, including those for ModivCare Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 24, 2025 3:43 AM UTC